20
Views
15
CrossRef citations to date
0
Altmetric
Original Article

Epirubicin and Ifosfamide in Advanced Soft Tissue Sarcoma: A Phase II Study

, , , , &
Pages 135-139 | Published online: 11 Jun 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Shailendra Verma & Vivien Bramwell. (2002) Dose-intensive chemotherapy in advanced adult soft tissue sarcoma. Expert Review of Anticancer Therapy 2:2, pages 201-215.
Read now
Ibrahim Güllü, Şuayib Yalçin, GÜLten Tekuzman, Ibrahim Barişlta, Necati Alkiş, Ismail Çelik, Nurullah Zengin, NilÜFer Güler, AyŞE Kars, EŞMen Baltali, Emin Kansu & DinÇEr Firat. (1996) High-Dose Ifosfamide by Infusion with Mesna in Advanced Refractory Sarcomas. Cancer Investigation 14:3, pages 239-242.
Read now

Articles from other publishers (13)

Hitoshi Kusaba, Hozumi Kumagai, Kyoko Inadomi, Tomoya Matsunobu, Katsumi Harimaya, Kotoe Takayoshi, Shuji Arita, Hiroshi Ariyama, Koichi Akashi & Eishi Baba. (2016) Efficacy analysis of the aprepitant-combined antiemetic prophylaxis for non-round cell soft-tissue sarcoma patients received adriamycin and ifosfamide therapy. Medicine 95:49, pages e5460.
Crossref
Sherif S. Morgan & Lee D. Cranmer. (2011) Systematic Therapy for Unresectable or Metastatic Soft-Tissue Sarcomas: Past, Present, and Future. Current Oncology Reports 13:4, pages 331-349.
Crossref
Shailendra Verma, Jawaid Younus, Denise Stys-Norman, Adam E. Haynes & Martin Blackstein. (2008) Meta-analysis of ifosfamide-based combination chemotherapy in advanced soft tissue sarcoma. Cancer Treatment Reviews 34:4, pages 339-347.
Crossref
Francis P. Worden, Jeremy M.G. Taylor, Janet S. Biermann, Vernon K. Sondak, Kirstin M. Leu, Rashmi Chugh, Cornelius J. McGinn, Mark M. Zalupski & Laurence H. Baker. (2005) Randomized Phase II Evaluation of 6 g/m 2 of Ifosfamide Plus Doxorubicin and Granulocyte Colony-Stimulating Factor (G-CSF) Compared With 12 g/m 2 of Ifosfamide Plus Doxorubicin and G-CSF in the Treatment of Poor-Prognosis Soft Tissue Sarcoma . Journal of Clinical Oncology 23:1, pages 105-112.
Crossref
Massimo LopezPatrizia ViciLuigi Di LauroSilvia Carpano. (2002) Increasing Single Epirubicin Doses in Advanced Soft Tissue Sarcomas. Journal of Clinical Oncology 20:5, pages 1329-1334.
Crossref
Peter Reichardt. (2002) High-dose chemotherapy in adult soft tissue sarcoma. Critical Reviews in Oncology/Hematology 41:2, pages 157-167.
Crossref
A. Santoro. (1999) Advanced soft tissue sarcoma: How many more trials with anthracyclines and ifosfamide?. Annals of Oncology 10:2, pages 151-154.
Crossref
Nada Babović, Svetislav Jelic, Nenad Milanović & Suzana Matković. (2018) Pilot Study of Daily Ifosfamide 1 g/m 2 Until Grade III Granulocytopenia as Second-Line Chemotherapy for Anthracycline-Pretreated Advanced Soft Tissue Sarcoma . Tumori Journal 84:6, pages 677-680.
Crossref
S. Leyvraz, M. Bacchi, T. Cerny, A. Lissoni, C. Sessa, A. Bressoud & R. Hermann. (1998) Phase I multicenter study of combined high-dose ifosfamide and doxorubicin in the treatment of advanced sarcomas. Annals of Oncology 9:8, pages 877-884.
Crossref
P. Reichardt. (1997) Should high-dose chemotherapy be used in the treatment of soft tissue sarcoma?. European Journal of Cancer 33:9, pages 1351-1354.
Crossref
S. Jelić, V. Kovc̆in, N. Milanović, N. Babović, M. Kreac̆ić, Z. Ristović, M. Vlajić & I. Filipović-Ljes̆ković. (1997) Randomised study of high-dose epirubicin versus high-dose epirubicin-cisplatin chemotherapy for advanced soft tissue sarcoma. European Journal of Cancer 33:2, pages 220-225.
Crossref
Alvaro A. Valle & William G. Kraybill. (1996) Review: Management of soft tissue sarcomas of the extremity in adults. Journal of Surgical Oncology 63:4, pages 271-279.
Crossref
H. J. Weh & D. K. Hossfeld. 1995. Soft Tissue Sarcomas in Adults. Soft Tissue Sarcomas in Adults 147 159 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.